Abbott Diabetes Care
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Abbott Diabetes Care sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
Abbott Diabetes Care: 26 sponsored US clinical trials, 3 recruiting.
Abbott Diabetes Care sponsors 26 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 19 completed. The most-studied condition in this pipeline is Diabete Mellitus, with 3 trials.
Top-decile sponsor footprint
Abbott Diabetes Care ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Glycemic Metrics and Patterns in People With and Without Prediabetes
NCT06921902
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
NCT06668935
FSL2 Post Approval Study for Pediatric and Young Adults Patients
NCT04959552
FreeStyle Libre 3 Continuous Glucose Monitoring System
NCT05962710
HbA1c Variation Study
NCT05189938
Study of an Interstitial Fluid Glucose Sensor
NCT05251116
T2 FSL2 Weight Loss
NCT05168306
Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes
NCT04604093
FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG
NCT04577976
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study
NCT04464772
FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study
NCT03820050
Freestyle Libre Flash Glucose Monitoring System
NCT03607448
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
NCT03502174
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study
NCT03448380
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
NCT03448367
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
NCT03369899
FreeStyle Libre Flash Accuracy Study
NCT03257501
FreeStyle Libre Flash Glucose Monitoring System Accuracy
NCT03159546
FreeStyle Libre Flash Glucose Monitoring System Accuracy Study
NCT03141892
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
NCT02336945
Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems
NCT02283411
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System
NCT02073058
Accuracy Characterization Study
NCT01932944
Navigator II Continuous Glucose Monitor Home Use Study
NCT01455064
Navigator 1.5 Accuracy Study
NCT01076218
Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System
NCT00920881
Therapeutic Areas
What is open in the Abbott Diabetes Care pipeline
3 recruiting of 26 indexed (12% open); 19 completed (73%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Diabete Mellitus (3 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Abbott Diabetes Care: open-pipeline peers nationwide
Peers matched on 26 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Abbott Diabetes Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
- Harvard Medical School (HMS and HSDM) · 26 trials · 15% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Medtronic Vascular · 12% recruiting · 26 trials
- Midwest Center for Metabolic and Cardiovascular Research · 12% recruiting · 26 trials
- VA Connecticut Healthcare System · 12% recruiting · 26 trials
- Barbara Ann Karmanos Cancer Institute · 12% recruiting · 139 trials
Related
What to do with this Abbott Diabetes Care page
26 registered trials is a research-attention snapshot, not an endorsement of Abbott Diabetes Care or any single study.
- 3 of Abbott Diabetes Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diabete Mellitus is the condition Abbott Diabetes Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabete Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Abbott Diabetes Care pipeline card: 26 registered trials from official public datasets.Report a data error.